hartwigmedical/actin
Mar 2026 – May 2026
3 Months active
Languages Used
Kotlin
Technical Skills
Kotlinbackend developmentdatabase managementreport generationalgorithm designdata modeling
Aya Ahmed
PROFILE
Aya Ahmed
Over a three-month period, contributed to the hartwigmedical/actin repository by delivering six features focused on clinical data evaluation and reporting. Work included refactoring treatment lookup logic for maintainability, expanding ICD code coverage, and implementing a range-based IHC scoring system to improve patient stratification. Enhanced variant evaluation logic to account for subclonal variants and introduced comprehensive creatinine clearance assessments using both daily total and urine concentration methods. Emphasized robust unit testing, data modeling, and backend development in Kotlin, ensuring changes were traceable and aligned with business needs. All features were delivered with a focus on code clarity and future extensibility.
Overall Statistics
Feature vs Bugs
100%Features
Repository Contributions
6Total
Bugs
0
Commits
6
Features
6
Lines of code
2,719
Activity Months3
Your Network
56 peopleSame Organization
@hartwigmedicalfoundation.nl34
Work History
May 2026
2 Commits • 2 Features
May 1, 2026In May 2026, the Actin project delivered two key features in hartwigmedical/actin that strengthen evaluation accuracy and measurement capabilities. 1) Enhanced Variant Evaluation accounts for subclonal variants in GeneHasVariantInExonRangeOfType and emits warnings when subclonal matches are detected. 2) Creatinine Clearance Evaluation added support for two measurement methods (daily total and urine concentration) with a comprehensive test suite. These changes improve clinical decision support reliability, reduce risk of misinterpretation, and broaden evaluation coverage. The work demonstrates strong testing discipline, clear traceability to work items ACTIN-2204 and ACTIN-1605, and maintainable code changes that enable future extension.
2 Commits • 2 Features
May 1, 2026In May 2026, the Actin project delivered two key features in hartwigmedical/actin that strengthen evaluation accuracy and measurement capabilities. 1) Enhanced Variant Evaluation accounts for subclonal variants in GeneHasVariantInExonRangeOfType and emits warnings when subclonal matches are detected. 2) Creatinine Clearance Evaluation added support for two measurement methods (daily total and urine concentration) with a comprehensive test suite. These changes improve clinical decision support reliability, reduce risk of misinterpretation, and broaden evaluation coverage. The work demonstrates strong testing discipline, clear traceability to work items ACTIN-2204 and ACTIN-1605, and maintainable code changes that enable future extension.
May 2026
April 2026
1 Commits • 1 Features
Apr 1, 2026Concise monthly summary for 2026-04 focused on delivering business value through a major scoring system overhaul, increased data accuracy, and robust test coverage for the IHC scoring feature in Actin. Overall context: Implemented a range-based IHC scoring model to replace the previous single-value system, enabling more nuanced patient stratification and analytics. All changes from conception to testing are aligned with downstream reporting and data integrity.
April 2026
1 Commits • 1 Features
Apr 1, 2026Concise monthly summary for 2026-04 focused on delivering business value through a major scoring system overhaul, increased data accuracy, and robust test coverage for the IHC scoring feature in Actin. Overall context: Implemented a range-based IHC scoring model to replace the previous single-value system, enabling more nuanced patient stratification and analytics. All changes from conception to testing are aligned with downstream reporting and data integrity.
March 2026
3 Commits • 3 Features
Mar 1, 2026In March 2026, ACTIN delivered focused enhancements to align the product with trial-matching workflows, improved data clarity for pneumonitis, and a refactor that simplifies treatment lookups. These changes strengthen business value by concentrating reporting on trial matching, expanding ICD code coverage, and reducing code complexity for future maintenance.
3 Commits • 3 Features
Mar 1, 2026In March 2026, ACTIN delivered focused enhancements to align the product with trial-matching workflows, improved data clarity for pneumonitis, and a refactor that simplifies treatment lookups. These changes strengthen business value by concentrating reporting on trial matching, expanding ICD code coverage, and reducing code complexity for future maintenance.
March 2026
Activity
Loading activity data...
Quality Metrics
Correctness96.6%
Maintainability86.8%
Architecture90.0%
Performance83.4%
AI Usage26.6%
Skills & Technologies
Programming Languages
Kotlin
Technical Skills
Kotlinalgorithm designbackend developmentdata modelingdatabase managementreport generationunit testing
Repositories Contributed To
Overview of all repositories you've contributed to across your timeline